SCI时时刷

search
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis
The impact of upadacitinib on rheumatoid arthritis (RA) symptoms was evaluated during the first 12 weeks of treat...
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
The aim of this work is to characterize which Minimal Disease Activity (MDA) domains are mainly achieved, based on differe...
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
Baricitinib, an orally available small-molecule inhibitor of Janus kinase (JAK)1 and JAK2, is indicated to treat active mo...
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Within the EULAR recommendations, patient education (PE) is stated as the basis of the management of axial spondyloarthrit...
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
The safety of tofacitinib in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) has been demonstrated in clinical stu...
Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
Lupus nephritis (LN) treatment aims to control and prevent flares and irreversible kidney damage. Around 30% of patients a...
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Rheumatoid arthritis (RA) often involves an altered T-cell subpopulation, higher levels of inflammatory cytokines, and aut...
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Ixekizumab (IXE) is an IgG4-type monoclonal antibody targeting IL-17A indicated alone or in combination with methotrexate,...
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
Recent changes to treatment guidelines for ankylosing spondylitis (AS) have listed first-line advanced therapies as tumor ...
Effectiveness of Shiatsu on Fatigue in Patients with Axial Spondyloarthritis: Protocol for a Randomized Cross-Over Pilot Study
Effectiveness of Shiatsu on Fatigue in Patients with Axial Spondyloarthritis: Protocol for a Randomized Cross-Over Pilot Study
Spondyloarthritis (SpA) is a serious chronic inflammatory rheumatism implying different painful and crippling symptoms tha...
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
This study evaluated the efficacy of the interleukin-17A inhibitor secukinumab in patients with oligoarticular psoriatic a...
Living with Systemic Sclerosis: A Patient and Physician Perspective
Living with Systemic Sclerosis: A Patient and Physician Perspective
The fears associated with being diagnosed with a disease unfamiliar to many, systemic sclerosis, is described by a patient...
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
The efficacy of abatacept is enhanced in anti-citrullinated protein antibody (ACPA) and rheumatoid factor (RF)-positive ve...
The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis
The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease of unexplained causes. Its pathological features include&nbs...